December 2024

Welcome to the Future of CML Treatment! The latest news from Novartis Basel, December 8, 2024 Novartis has just released groundbreaking results from the Phase III ASC4FIRST trial, showcasing the superior efficacy of Scemblix® (asciminib) in treating Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase (Ph+ CML-CP) patients. The study compared Scemblix to standard-of-care tyrosine…

Revolutionizing R-R cHL Treatment: Affimed’s Acimtamig and AlloNK Combination Proves Safe and Effective for Relapsed/Refractory Classical Hodgkin Lymphoma Patients MANNHEIM, Germany, Dec. 08, 2024 (GLOBE NEWSWIRE) — Affimed N.V. (Nasdaq: AFMD) Affimed, a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announced the presentation of data in a…

Rosen Law Firm Reminds Xiao-I Corporation Investors of December 16 Deadline NEW YORK, Dec. 8, 2024 /PRNewswire/ — Overview: Rosen Law Firm, a global investor rights law firm, is reminding purchasers of Xiao-I Corporation (NASDAQ: AIXI) about the upcoming lead plaintiff deadline on December 16, 2024. This deadline applies to investors who bought American depository…

Understanding the Celsius Holdings Securities Class Action Lawsuit Introduction RADNOR, PA / ACCESSWIRE / December 8, 2024 / The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that a securities class action lawsuit has been filed against Celsius Holdings, Inc. (“Celsius”) (NASDAQ:CELH) on behalf of those who purchased or otherwise acquired Celsius…

U.S. Equity Markets Reach Record Highs Amid Lukewarm Employment Data Market Update This week, U.S. equity markets saw a surge to fresh record-highs as benchmark interest rates trended lower. The boost in market performance came after a critical release of employment data for November, revealing lukewarm labor market trends. This report, often referred to as…

Lost Money on Evolv Technologies Holdings, Inc. (NASDAQ:EVLV)? Here’s What You Need to Know What Happened? So you’ve found yourself in a bit of a pickle, huh? Lost some hard-earned cash on your Evolv Technologies Holdings, Inc. investment? Well, you’re not alone. But fear not, my friend, there may be a light at the end…

Levi & Korsinsky Investigates Applied Therapeutics, Inc. for Securities Violations New York, NY / ACCESSWIRE / December 8, 2024 Levi & Korsinsky, a leading securities litigation firm, has announced that it is conducting an investigation into Applied Therapeutics, Inc. (NASDAQ:APLT) for potential violations of federal securities laws. The investigation comes in response to a press…